(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and ...
NEW YORK (Reuters) - Eli Lilly & Co on Tuesday will confront the first U.S. trial over allegations it failed to warn users of its popular antidepressant Cymbalta that they could suffer severe ...
The FDA is recalling thousands of bottles of duloxetine, the generic form of Cymbalta, due to high levels of a cancer-causing chemical found during manufacturing. The recall, announced on October 10, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results